Pure Bioscience, Inc. SEC filings PURE
Pure Bioscience, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to May 24, 1996. Its latest annual report, Form 10-K, was filed on Oct 29, 2026 for the period ended Jul 31, 2026. The latest quarterly report (Form 10-Q) was filed on Jun 15, 2026, covering the quarter ended Apr 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on July 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Dec 30, 2025 | Dec 30, 2025 |
| PRE 14A | Preliminary proxy statement | Dec 18, 2025 | Dec 18, 2025 |
| DEF 14A | Proxy statement | Dec 12, 2024 | Dec 12, 2024 |
| DEF 14A | Proxy statement | Jan 10, 2024 | Jan 10, 2024 |
| PRE 14A | Preliminary proxy statement | Dec 19, 2023 | Dec 19, 2023 |
| DEF 14A | Proxy statement | Dec 23, 2022 | Dec 23, 2022 |
| DEF 14A | Proxy statement | Dec 20, 2021 | Dec 20, 2021 |
| DEF 14A | Proxy statement | Dec 8, 2020 | Dec 8, 2020 |
| PRE 14A | Preliminary proxy statement | Nov 20, 2020 | Nov 20, 2020 |
| DEF 14A | Proxy statement | Dec 20, 2019 | Dec 19, 2019 |
| DEF 14A | Proxy statement | Dec 20, 2018 | Dec 20, 2018 |
| DEFA14A | Additional proxy material | Dec 8, 2017 | — |
| DEF 14A | Proxy statement | Dec 8, 2017 | Dec 8, 2017 |
| DEFA14A | Additional proxy material | Dec 8, 2016 | — |
| DEF 14A | Proxy statement | Dec 8, 2016 | Dec 8, 2016 |
| DEFA14A | Additional proxy material | Dec 23, 2015 | — |
| DEF 14A | Proxy statement | Dec 23, 2015 | Feb 4, 2016 |
| DEF 14A | Proxy statement | Dec 5, 2014 | Jan 15, 2015 |
| DEF 14A | Proxy statement | Dec 20, 2013 | Jan 30, 2014 |
| DEF 14A | Proxy statement | Jul 12, 2012 | Jul 12, 2012 |
| DEFA14A | Additional proxy material | Jan 20, 2011 | — |
| DEF 14A | Proxy statement | Nov 30, 2010 | Nov 19, 2010 |
| PRE 14A | Preliminary proxy statement | Nov 19, 2010 | Nov 19, 2010 |
| DEF 14A | Proxy statement | Nov 25, 2009 | Nov 25, 2009 |
| DEFA14A | Additional proxy material | Nov 26, 2008 | — |
| DEF 14A | Proxy statement | Nov 26, 2008 | Nov 26, 2008 |
| DEF 14A | Proxy statement | Jan 23, 2007 | Jan 23, 2007 |
| PRE 14A | Preliminary proxy statement | Jan 12, 2007 | Jan 12, 2007 |
| DEF 14A | Proxy statement | Mar 10, 2004 | Mar 10, 2004 |
| PRE 14A | Preliminary proxy statement | Nov 25, 2003 | Nov 25, 2003 |
| DEF 14A | Proxy statement | Aug 21, 2003 | Aug 21, 2003 |
| PRE 14A | Preliminary proxy statement | Aug 11, 2003 | Aug 11, 2003 |
| DEF 14A | Proxy statement | Feb 15, 2002 | Feb 15, 2002 |
| PRE 14A | Preliminary proxy statement | Feb 5, 2002 | Feb 5, 2002 |
| DEF 14A | Proxy statement | Nov 28, 2000 | Nov 28, 2000 |
| PRE 14A | Preliminary proxy statement | Nov 17, 2000 | Nov 17, 2000 |
| DEF 14A | Proxy statement | Nov 29, 1999 | Nov 29, 1999 |
| DEF 14A | Proxy statement | Dec 14, 1998 | Nov 20, 1998 |
| PRE 14A | Preliminary proxy statement | Nov 9, 1998 | Nov 20, 1998 |
| DEF 14A | Proxy statement | Dec 8, 1997 | Nov 24, 1997 |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Miscellaneous Chemical Products (SIC 2890)
- Listed as
- PURE (OTC)
- Fiscal year ends
- July 31
- Incorporated in
- DE
- Headquarters
- El Cajon, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1006028
- Former names
- PURE BIOSCIENCE (until Mar 17, 2011); INNOVATIVE MEDICAL SERVICES (until Sep 2, 2003)
Other Miscellaneous Chemical Products companies
- Element Solutions Inc ESI
- Cabot Corp CBT
- WD 40 Co WDFC
- Flotek Industries INC/CN/ FTK
- Orion S.A. OEC
- ASP Isotopes Inc. ASPI
- Arq, Inc. ARQ
- Flexible Solutions International Inc FSI
Source: SEC EDGAR filings. This is company-reported data, not investment advice.